Cullinan Management, Inc. (NASDAQ:CGEM)’s share price rose 19.6% on Wednesday . The company traded as high as $35.41 and last traded at $35.38. Approximately 603,792 shares changed hands during mid-day trading, an increase of 17% from the average daily volume of 517,831 shares. The stock had previously closed at $29.59.
Cullinan Management Company Profile (NASDAQ:CGEM)
Cullinan Oncology, LLC, a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. Its lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with non-small cell lung cancer.
Recommended Story: How to Calculate Compound Annual Growth Rate (CAGR)
Receive News & Ratings for Cullinan Management Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cullinan Management and related companies with MarketBeat.com's FREE daily email newsletter.